We are live on ! Find out more
RG

Rathbones Group Portfolio holdings

AUM $27.1B
1-Year Est. Return 20.2%
This Fund
S&P 500
This Quarter Est. Return
+5.36%
1 Year Est. Return
+20.2%
3 Year Est. Return
+79.31%
5 Year Est. Return
+95.63%
10 Year Est. Return
+508.18%
AUM
$3.19B
AUM Growth
+$153M
Cap. Flow
+$17.6M
Cap. Flow %
0.55%
Top 10 Hldgs %
29.55%
Holding
324
New
11
Increased
97
Reduced
113
Closed
9

Top Buys

Rank Stock Value
1
RNG icon
RingCentral
RNG
+$27.5M
2
BSX icon
Boston Scientific
BSX
+$25.3M
3
LW icon
Lamb Weston
LW
+$6.07M
4
ADSK icon
Autodesk
ADSK
+$5.95M
5
FCFS icon
FirstCash
FCFS
+$5.8M

Top Sells

Rank Stock Value
1
ABMD
Abiomed Inc
ABMD
+$34.4M
2
BKNG icon
Booking.com
BKNG
+$22.2M
3
WEC icon
WEC Energy
WEC
+$7.17M
4
MS icon
Morgan Stanley
MS
+$4.67M
5
INTC icon
Intel
INTC
+$4.26M

Sector Composition

Rank Sector Weight
1 Technology 20.97%
2 Financials 20.16%
3 Healthcare 11.15%
4 Consumer Staples 11.15%
5 Communication Services 9.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NKTR icon
251
Nektar Therapeutics
NKTR
$2.32B
$363K 0.01%
680
EXPD icon
252
Expeditors International
EXPD
$23.1B
$360K 0.01%
4,746
+109
+2% +$8.23K
BKU icon
253
Bankunited
BKU
$3.34B
$355K 0.01%
10,535
-600
-5% -$20.7K
BNDX icon
254
Vanguard Total International Bond ETF
BNDX
$81.8B
$355K 0.01%
6,195
+140
+2% +$7.87K
MDY icon
255
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.9B
$355K 0.01%
1,000
MKC.V icon
256
McCormick & Company Voting
MKC.V
$13.6B
$349K 0.01%
4,500
IBND icon
257
State Street SPDR Bloomberg International Corporate Bond ETF
IBND
$453M
$348K 0.01%
+10,190
New +$340K
ALXN
258
DELISTED
Alexion Pharmaceuticals
ALXN
$348K 0.01%
2,660
TMUS icon
259
T-Mobile US
TMUS
$193B
$347K 0.01%
4,680
+1,180
+34% +$87.6K
AVGO icon
260
Broadcom
AVGO
$1.86T
$334K 0.01%
11,620
+120
+1% +$3.5K
SYK icon
261
Stryker
SYK
$120B
$331K 0.01%
+1,609
New +$307K
IGM icon
262
iShares Expanded Tech Sector ETF
IGM
$10.1B
$330K 0.01%
9,180
PSX icon
263
Phillips 66
PSX
$84.2B
$325K 0.01%
3,479
-575
-14% -$51.6K
FISV
264
Fiserv Inc
FISV
$26.6B
$319K 0.01%
3,500
NUVA
265
DELISTED
NuVasive, Inc.
NUVA
$313K 0.01%
5,350
FSLR icon
266
First Solar
FSLR
$22.1B
$312K 0.01%
4,743
+278
+6% +$16.7K
BF.B icon
267
Brown-Forman Class B
BF.B
$11.8B
$310K 0.01%
5,587
-119
-2% -$6.35K
UN
268
DELISTED
Unilever NV New York Registry Shares
UN
$309K 0.01%
5,094
CEF icon
269
Sprott Physical Gold and Silver Trust
CEF
$7.4B
$308K 0.01%
23,316
+12,396
+114% +$155K
TRHC
270
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$303K 0.01%
6,060
AIG icon
271
American International
AIG
$41.5B
$294K 0.01%
+5,520
New +$275K
EOG icon
272
EOG Resources
EOG
$77.9B
$283K 0.01%
3,043
GSK icon
273
GSK
GSK
$101B
$275K 0.01%
5,501
YUM icon
274
Yum! Brands
YUM
$40.7B
$271K 0.01%
2,450
+100
+4% +$10.4K
TMO icon
275
Thermo Fisher Scientific
TMO
$212B
$263K 0.01%
895

Similar funds

Rathbones Group's Q2 2019 Portfolio in Review

As of Q2 2019, Rathbones Group held 324 positions worth $3.19B, up 5% from $3.04B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Rathbones Group's Q2 2019 filing shows 11 new, 97 increased, 113 reduced and 9 closed positions. Its largest new stake was RingCentral: 238,300 shares worth $27.4M. The largest sale was Abiomed Inc, an estimated $34.4M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

  • Rathbones Group's largest Q2 2019 buy was RingCentral: 238,300 shares worth $27.4M.
  • Rathbones Group added most to Boston Scientific in Q2 2019, an estimated $25.3M increase.
  • Rathbones Group's biggest Q2 2019 reduction was Abiomed Inc, cutting an estimated $34.4M.
  • Rathbones Group fully exited Goldcorp Inc in Q2 2019, selling an estimated $461K.
  • Rathbones Group's ten largest holdings make up 30% of its $3.19B portfolio in Q2 2019.
  • Rathbones Group opened 11 new positions and closed 9 in Q2 2019.
  • Rathbones Group's portfolio value rose 5% quarter-over-quarter to $3.19B.

Based on Rathbones Group's 13F filing for Q2 2019, filed 12 Aug 2019.